{"transactions":[{"id":1918880,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2023-04-18T01:00:07.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":2600000,"price":1.27,"value":3302000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the sale of shares in a privately negotiated sale transaction. The Reporting Person's sales reported herein are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with previously reported transactions by the Reporting Person (the \"Previous Transactions\"). Because the sale reported herein occurred at a price lower than the price the Reporting Person sold shares in the Previous Transactions, there are no additional recoverable profits subject to disgorgement in connection with the sale reported herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the sale of shares in a privately negotiated sale transaction. The Reporting Person's sales reported herein are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with previously reported transactions by the Reporting Person (the \"Previous Transactions\"). Because the sale reported herein occurred at a price lower than the price the Reporting Person sold shares in the Previous Transactions, there are no additional recoverable profits subject to disgorgement in connection with the sale reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":9667707,"source":{"system":"sec-edgar","filing":"0001493152-23-012664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223012664/ownership.xml","form_type":"4"}},{"id":2015422,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap (right to buy)","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":407874,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":0,"derivative":{"exercise_price":3.141,"exercise_date":"2025-12-31","expiration_date":"2025-12-31","underlying":"Common stock, par value $0.0001","underlying_shares":407874},"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015421,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap (right to buy)","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":760000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":407874,"derivative":{"exercise_price":3.339,"exercise_date":"2025-12-31","expiration_date":"2025-12-31","underlying":"Common stock, par value $0.0001","underlying_shares":760000},"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015420,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap (right to buy)","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":730750,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":1167874,"derivative":{"exercise_price":3.462,"exercise_date":"2025-12-31","expiration_date":"2025-12-31","underlying":"Common stock, par value $0.0001","underlying_shares":730750},"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015419,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap (right to buy)","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":172816,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 30, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of Issuer's common stock on January 20, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 30, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of Issuer's common stock on January 20, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":0,"derivative":{"exercise_price":3.339,"exercise_date":"2025-12-30","expiration_date":"2025-12-30","underlying":"Common stock, par value $0.0001","underlying_shares":172816},"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015418,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap (right to buy)","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":527184,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On November 23, 2022 the Reporting Person entered into an equity swap agreement with a third party. The reported equity swap was on a basket of securities, which included shares of the Issuer's common stock. Under the equity swap, the third party was obligated to pay to the Reporting Person the aggregate increase, if any, in value of the basket of securities between November 23, 2022 and December 31, 2025. In connection with the optional partial early termination of the equity swap agreement, the third party became obligated to pay to the Reporting Person the excess of the price per share of the Issuer's common stock on each of January 20, 2023, January 23, 2023, January 24, 2023 and January 25, 2023 over the price per share of the Issuer's common stock on November 23, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":1898624,"derivative":{"exercise_price":3.339,"exercise_date":"2025-12-31","expiration_date":"2025-12-31","underlying":"Common stock, par value $0.0001","underlying_shares":527184},"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015417,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-25","kind":"purchase","acquired":true,"shares":407874,"price":2.307,"value":940965.318,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.42 per share, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":12267707,"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015416,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-24","kind":"purchase","acquired":true,"shares":760000,"price":2.463,"value":1871880.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.375 to $2.785 per share, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":11859833,"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015415,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-23","kind":"purchase","acquired":true,"shares":530750,"price":2.595,"value":1377296.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40 to $2.75 per share, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":11099833,"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2015414,"issuer":{"id":4527,"kind":"organization","name":"Porch Group, Inc.","symbol":"PRCH"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2023-02-15T02:05:26.000Z","date":"2023-01-20","kind":"purchase","acquired":true,"shares":474220,"price":2.463,"value":1168003.86,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The amount of any recoverable short swing profit from the Reporting Person resulting from the reported transactions will be calculated pursuant to Rule 16b-6(c)(2), and will be remitted to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.295 to $2.565 per share, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (\"PWAM\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\") and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, collectively with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in the securities reported herein."}],"balance_after":10569083,"source":{"system":"sec-edgar","filing":"0001493152-23-005095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000149315223005095/ownership.xml","form_type":"4"}},{"id":2571800,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-09-13T20:30:38.000Z","date":"2021-08-27","kind":"other","acquired":false,"shares":6000002,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 27, 2021, pursuant to an Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc. (the \"Company\"), Elanco Animal Health Incorporated (\"Elanco\") and Knight Merger Sub, Inc., a wholly owned subsidiary of Elanco (\"Merger Sub\"), Merger Sub merged with and into the Company with the Company surviving as the wholly owned subsidiary of Elanco (the \"Merger\"). Immediately prior to the effective time of the Merger, each share of common stock, par value $0.0001 per share, of the Company was cancelled and automatically converted into the right to receive $9.25 per share in cash."},{"field":"shares","element":"transactionShares","label":"F1","text":"On August 27, 2021, pursuant to an Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc. (the \"Company\"), Elanco Animal Health Incorporated (\"Elanco\") and Knight Merger Sub, Inc., a wholly owned subsidiary of Elanco (\"Merger Sub\"), Merger Sub merged with and into the Company with the Company surviving as the wholly owned subsidiary of Elanco (the \"Merger\"). Immediately prior to the effective time of the Merger, each share of common stock, par value $0.0001 per share, of the Company was cancelled and automatically converted into the right to receive $9.25 per share in cash."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 27, 2021, pursuant to an Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc. (the \"Company\"), Elanco Animal Health Incorporated (\"Elanco\") and Knight Merger Sub, Inc., a wholly owned subsidiary of Elanco (\"Merger Sub\"), Merger Sub merged with and into the Company with the Company surviving as the wholly owned subsidiary of Elanco (the \"Merger\"). Immediately prior to the effective time of the Merger, each share of common stock, par value $0.0001 per share, of the Company was cancelled and automatically converted into the right to receive $9.25 per share in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905718-21-001189","document":"kindred_fm4aug272021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821001189/kindred_fm4aug272021.xml","form_type":"4"}},{"id":2621972,"issuer":{"id":93736,"kind":"organization","name":"ROVER GROUP, INC.","symbol":"ROVR"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2021-07-29T21:01:53.000Z","date":"2021-07-27","kind":"purchase","acquired":true,"shares":78807,"price":9.4537,"value":745017.7359,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.405 to $9.50 per share, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. As of July 27, 2021, PWIMF held 1,956,211 shares of Class A common stock, par value $0.0001 per share (the \"Common Stock\") of Nebula Caravel Acquisition Corp. (the \"Company\"), and PWPI held 192,596 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2148807,"source":{"system":"sec-edgar","filing":"0000905718-21-000971","document":"nebulacaravel_fm4jul272021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000971/nebulacaravel_fm4jul272021.xml","form_type":"4"}},{"id":2631732,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2021-07-17T01:13:16.000Z","date":"2021-07-14","kind":"other","acquired":true,"shares":6029768,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 14, 2021, pursuant to an agreement and plan of merger (the \"Merger Agreement\") by and among Rodgers Silicon Valley Acquisition Corp. (\"RSVA\"), RSVAC Merger Sub Inc., a wholly-owned subsidiary of RSVA (\"Merger Sub\"), and Enovix Corporation (\"Enovix\"), the Issuer completed its initial business combination (the \"Business Combination\"). Pursuant to the Merger Agreement, Merger Sub merged with and into Enovix with Enovix surviving the merger as a wholly owned subsidiary of RSVA. As a result of the Business Combination, RSVA changed its name to Enovix Corporation. In connection with the consummation of the Business Combination, each share of Enovix Series P-2 Preferred Stock, par value $0.001 per share, held in the aggregate by PWIMF and PWPI was converted into an aggregate of 6,029,768 shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 14, 2021, pursuant to an agreement and plan of merger (the \"Merger Agreement\") by and among Rodgers Silicon Valley Acquisition Corp. (\"RSVA\"), RSVAC Merger Sub Inc., a wholly-owned subsidiary of RSVA (\"Merger Sub\"), and Enovix Corporation (\"Enovix\"), the Issuer completed its initial business combination (the \"Business Combination\"). Pursuant to the Merger Agreement, Merger Sub merged with and into Enovix with Enovix surviving the merger as a wholly owned subsidiary of RSVA. As a result of the Business Combination, RSVA changed its name to Enovix Corporation. In connection with the consummation of the Business Combination, each share of Enovix Series P-2 Preferred Stock, par value $0.001 per share, held in the aggregate by PWIMF and PWPI was converted into an aggregate of 6,029,768 shares of the Issuer's Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. On July 14, 2021, the date of the transaction reported in this report, PWIMF held 11,348,649 shares of common stock, par value $0.0001 (\"Common Stock\"), of Enovix Corporation (the \"Issuer\") and PWPI held 1,123,976 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":12472625,"source":{"system":"sec-edgar","filing":"0000905718-21-000932","document":"enovix_fm4jul142021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000932/enovix_fm4jul142021.xml","form_type":"4"}},{"id":2631731,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2021-07-17T01:13:16.000Z","date":"2021-07-14","kind":"purchase","acquired":true,"shares":2142857,"price":14,"value":29999998.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. On July 14, 2021, the date of the transaction reported in this report, PWIMF held 11,348,649 shares of common stock, par value $0.0001 (\"Common Stock\"), of Enovix Corporation (the \"Issuer\") and PWPI held 1,123,976 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6442857,"source":{"system":"sec-edgar","filing":"0000905718-21-000932","document":"enovix_fm4jul142021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000932/enovix_fm4jul142021.xml","form_type":"4"}},{"id":2678887,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2021-06-07T22:58:13.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":345383,"price":6.9505,"value":2400584.5415,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.91 to $6.97 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), though one or more affiliated entities, is the controlling manager of the Reporting Person. As of the latest transaction reported on this Form 4, PWIMF held 5,437,412 shares of Common Stock, and PWPI held 562,590 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6000002,"source":{"system":"sec-edgar","filing":"0000905718-21-000762","document":"kindred_fm4jun32021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000762/kindred_fm4jun32021.xml","form_type":"4"}},{"id":2678886,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2021-06-07T22:58:13.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":69600,"price":6.7973,"value":473092.08,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), though one or more affiliated entities, is the controlling manager of the Reporting Person. As of the latest transaction reported on this Form 4, PWIMF held 5,437,412 shares of Common Stock, and PWPI held 562,590 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6345385,"source":{"system":"sec-edgar","filing":"0000905718-21-000762","document":"kindred_fm4jun32021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000762/kindred_fm4jun32021.xml","form_type":"4"}},{"id":2764147,"issuer":{"id":1057,"kind":"organization","name":"ThredUp Inc.","symbol":"TDUP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2021-04-02T01:11:24.000Z","date":"2021-03-30","kind":"other","acquired":false,"shares":7844390,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. Immediately following the closing of the Issuer's initial public offering, (i) PWIMF held 455,301 shares of the Issuer's Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\"), and 7,917,253 shares of the Issuer's Class B Common Stock, par value $0.0001 per share (\"Class B Common Stock\"), and (ii) PWPI held 44,699 shares of the Issuer's Class A Common Stock and 798,736 shares of the Issuer's Class B Common Stock. Class B Common Stock is convertible into Class A Common Stock at any time at the option of the holder."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7844390},"source":{"system":"sec-edgar","filing":"0000905718-21-000519","document":"thredup_fm4mar302021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1484778/000090571821000519/thredup_fm4mar302021.xml","form_type":"4"}},{"id":2764146,"issuer":{"id":1057,"kind":"organization","name":"ThredUp Inc.","symbol":"TDUP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2021-04-02T01:11:24.000Z","date":"2021-03-30","kind":"other","acquired":false,"shares":8715989,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the completion of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, par value $0.0001 per share (\"Common Stock\"), each share of Common Stock was reclassified into one share of Class B Common Stock pursuant to a reclassification exempt under Rule 16b-7."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the completion of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, par value $0.0001 per share (\"Common Stock\"), each share of Common Stock was reclassified into one share of Class B Common Stock pursuant to a reclassification exempt under Rule 16b-7."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the closing of the Issuer's initial public offering, each share of Series F Preferred Stock automatically converted into one share of the Issuer's Common Stock on a one-for-one basis, and was then reclassified into one share of Class B Common Stock. The shares of Series F Preferred Stock have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. Immediately following the closing of the Issuer's initial public offering, (i) PWIMF held 455,301 shares of the Issuer's Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\"), and 7,917,253 shares of the Issuer's Class B Common Stock, par value $0.0001 per share (\"Class B Common Stock\"), and (ii) PWPI held 44,699 shares of the Issuer's Class A Common Stock and 798,736 shares of the Issuer's Class B Common Stock. Class B Common Stock is convertible into Class A Common Stock at any time at the option of the holder."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905718-21-000519","document":"thredup_fm4mar302021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1484778/000090571821000519/thredup_fm4mar302021.xml","form_type":"4"}},{"id":2764145,"issuer":{"id":1057,"kind":"organization","name":"ThredUp Inc.","symbol":"TDUP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock, par value $0.0001","published_at":"2021-04-02T01:11:24.000Z","date":"2021-03-30","kind":"other","acquired":true,"shares":8715989,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the completion of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, par value $0.0001 per share (\"Common Stock\"), each share of Common Stock was reclassified into one share of Class B Common Stock pursuant to a reclassification exempt under Rule 16b-7."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the completion of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, par value $0.0001 per share (\"Common Stock\"), each share of Common Stock was reclassified into one share of Class B Common Stock pursuant to a reclassification exempt under Rule 16b-7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. Immediately following the closing of the Issuer's initial public offering, (i) PWIMF held 455,301 shares of the Issuer's Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\"), and 7,917,253 shares of the Issuer's Class B Common Stock, par value $0.0001 per share (\"Class B Common Stock\"), and (ii) PWPI held 44,699 shares of the Issuer's Class A Common Stock and 798,736 shares of the Issuer's Class B Common Stock. Class B Common Stock is convertible into Class A Common Stock at any time at the option of the holder."}],"balance_after":8715989,"source":{"system":"sec-edgar","filing":"0000905718-21-000519","document":"thredup_fm4mar302021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1484778/000090571821000519/thredup_fm4mar302021.xml","form_type":"4"}},{"id":2764144,"issuer":{"id":1057,"kind":"organization","name":"ThredUp Inc.","symbol":"TDUP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A common stock, par value $0.0001","published_at":"2021-04-02T01:11:24.000Z","date":"2021-03-30","kind":"purchase","acquired":true,"shares":500000,"price":14,"value":7000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. Immediately following the closing of the Issuer's initial public offering, (i) PWIMF held 455,301 shares of the Issuer's Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\"), and 7,917,253 shares of the Issuer's Class B Common Stock, par value $0.0001 per share (\"Class B Common Stock\"), and (ii) PWPI held 44,699 shares of the Issuer's Class A Common Stock and 798,736 shares of the Issuer's Class B Common Stock. Class B Common Stock is convertible into Class A Common Stock at any time at the option of the holder."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0000905718-21-000519","document":"thredup_fm4mar302021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484778/000090571821000519/thredup_fm4mar302021.xml","form_type":"4"}},{"id":2888317,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2021-02-01T23:00:23.000Z","date":"2021-01-29","kind":"sale","acquired":false,"shares":3300,"price":5.07,"value":16731.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.03 to $5.10 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. As of January 29, 2021, PWIMF held 5,808,785 shares of Common Stock, and PWPI held 606,200 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6414985,"source":{"system":"sec-edgar","filing":"0000905718-21-000122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000122/ownership.xml","form_type":"4"}},{"id":2888316,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2021-02-01T23:00:23.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":210472,"price":5.25,"value":1104978.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.78 per share, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\"), through one or more affiliated entities, is the controlling manager of the Reporting Person. As of January 29, 2021, PWIMF held 5,808,785 shares of Common Stock, and PWPI held 606,200 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6418285,"source":{"system":"sec-edgar","filing":"0000905718-21-000122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571821000122/ownership.xml","form_type":"4"}},{"id":2946082,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2020-12-14T22:22:39.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":40043,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Units were purchased for $12.37 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $12.00 to $12.42 per Unit, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Warrants will become exercisable at any time commencing on the later of (a) 12 months from the closing of the offering or (b) 30 days after the completion of the Company's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Warrants will expire five years after the completion of the Company's initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 11, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,912,074 Units and PWPI held 387,926 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2149999,"derivative":{"exercise_price":11.5,"underlying":"Common stock, par value $0.0001","underlying_shares":40043},"source":{"system":"sec-edgar","filing":"0000905718-20-001167","document":"rodgers_fm4dec102020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001167/rodgers_fm4dec102020.xml","form_type":"4"}},{"id":2946081,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2020-12-14T22:22:39.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":193300,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Units were purchased for $11.49 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $11.40 to $11.50 per Unit, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Warrants will become exercisable at any time commencing on the later of (a) 12 months from the closing of the offering or (b) 30 days after the completion of the Company's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Warrants will expire five years after the completion of the Company's initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 11, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,912,074 Units and PWPI held 387,926 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2109956,"derivative":{"exercise_price":11.5,"underlying":"Common stock, par value $0.0001","underlying_shares":193300},"source":{"system":"sec-edgar","filing":"0000905718-20-001167","document":"rodgers_fm4dec102020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001167/rodgers_fm4dec102020.xml","form_type":"4"}},{"id":2946080,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2020-12-14T22:22:39.000Z","date":"2020-12-11","kind":"purchase","acquired":true,"shares":80087,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Units were purchased for $12.37 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $12.00 to $12.42 per Unit, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 11, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,912,074 Units and PWPI held 387,926 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":4300000,"source":{"system":"sec-edgar","filing":"0000905718-20-001167","document":"rodgers_fm4dec102020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001167/rodgers_fm4dec102020.xml","form_type":"4"}},{"id":2946079,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2020-12-14T22:22:39.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":386600,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Units were purchased for $11.49 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $11.40 to $11.50 per Unit, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 11, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,912,074 Units and PWPI held 387,926 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":4219913,"source":{"system":"sec-edgar","filing":"0000905718-20-001167","document":"rodgers_fm4dec102020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001167/rodgers_fm4dec102020.xml","form_type":"4"}},{"id":2953078,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2020-12-09T01:23:00.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":63701,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Units were purchased for $11.44 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $11.21 to $12.30 per Unit, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Warrants will become exercisable at any time commencing on the later of (a) 12 months from the closing of the offering or (b) 30 days after the completion of the Company's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Warrants will expire five years after the completion of the Company's initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 8, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,487,496 Units and PWPI held 345,817 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":1916656,"derivative":{"exercise_price":11.5,"underlying":"Common stock, par value $0.0001","underlying_shares":63701},"source":{"system":"sec-edgar","filing":"0000905718-20-001158","document":"rodgers_fm4dec42020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001158/rodgers_fm4dec42020.xml","form_type":"4"}},{"id":2953077,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2020-12-09T01:23:00.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":352955,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Units were purchased for $10.92 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $10.75 to $11.00 per Unit, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Warrants will become exercisable at any time commencing on the later of (a) 12 months from the closing of the offering or (b) 30 days after the completion of the Company's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Warrants will expire five years after the completion of the Company's initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 8, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,487,496 Units and PWPI held 345,817 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":1852955,"derivative":{"exercise_price":11.5,"underlying":"Common stock, par value $0.0001","underlying_shares":352955},"source":{"system":"sec-edgar","filing":"0000905718-20-001158","document":"rodgers_fm4dec42020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001158/rodgers_fm4dec42020.xml","form_type":"4"}},{"id":2953076,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2020-12-09T01:23:00.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":127402,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Units were purchased for $11.44 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $11.21 to $12.30 per Unit, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 8, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,487,496 Units and PWPI held 345,817 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3833313,"source":{"system":"sec-edgar","filing":"0000905718-20-001158","document":"rodgers_fm4dec42020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001158/rodgers_fm4dec42020.xml","form_type":"4"}},{"id":2953075,"issuer":{"id":5188,"kind":"organization","name":"Enovix Corp","symbol":"ENVX"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.0001","published_at":"2020-12-09T01:23:00.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":705911,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities reported herein are held as units (\"Units\"), with each Unit consisting of one share of common stock, par value $0.0001 per share (\"Common Stock\"), of Rodgers Silicon Valley Acquisition Corp. (the \"Company\") and one-half of one warrant to purchase one share of Common Stock at an exercise price of $11.50 per share (the \"Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Units were purchased for $10.92 per Unit. This price is a weighted average price. These Units were bought in multiple transactions ranging from $10.75 to $11.00 per Unit, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Units purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. On December 8, 2020, the date of the latest transaction reported in this statement, PWIMF held 3,487,496 Units and PWPI held 345,817 Units. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3705911,"source":{"system":"sec-edgar","filing":"0000905718-20-001158","document":"rodgers_fm4dec42020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820001158/rodgers_fm4dec42020.xml","form_type":"4"}},{"id":3096375,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2020-07-01T01:30:52.000Z","date":"2020-06-26","kind":"sale","acquired":false,"shares":115136,"price":4.71,"value":542290.56,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of June 26, 2020, PWIMF held 6,000,439 shares of Common Stock, and PWPI held 628,318 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities"}],"balance_after":6628757,"source":{"system":"sec-edgar","filing":"0000905718-20-000678","document":"kindredbiosc_fm4jun262020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000678/kindredbiosc_fm4jun262020.xml","form_type":"4"}},{"id":3105141,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-19T01:30:15.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":400000,"price":13.9,"value":5560000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions with prices ranging from $13.90 to $13.95 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On June 17, 2020, the date of the latest transaction reported in this statement, PWIMF held 2,013,683 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 199,522 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2213205,"source":{"system":"sec-edgar","filing":"0000905718-20-000601","document":"sciplay_fm4jun172020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000601/sciplay_fm4jun172020.xml","form_type":"4"}},{"id":3114390,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-11T01:30:14.000Z","date":"2020-06-09","kind":"sale","acquired":false,"shares":15054,"price":15.25,"value":229573.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $15.25 to $15.27 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On June 9, 2020, the date of the latest transaction reported in this statement, PWIMF held 2,378,574 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 234,631 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2613205,"source":{"system":"sec-edgar","filing":"0000905718-20-000568","document":"sciplay_fm4jun82020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000568/sciplay_fm4jun82020.xml","form_type":"4"}},{"id":3114389,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-11T01:30:14.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1450,"price":15.25,"value":22112.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On June 9, 2020, the date of the latest transaction reported in this statement, PWIMF held 2,378,574 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 234,631 shares of Common Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2628259,"source":{"system":"sec-edgar","filing":"0000905718-20-000568","document":"sciplay_fm4jun82020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000568/sciplay_fm4jun82020.xml","form_type":"4"}},{"id":3126571,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-03T01:30:15.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":584400,"price":13.92,"value":8134848.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $13.90 to $14.35 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 1, 2020, the date of the latest transaction reported in this statement, PWIMF held 2,394,058 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 235,651 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2629709,"source":{"system":"sec-edgar","filing":"0000905718-20-000539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000539/ownership.xml","form_type":"4"}},{"id":3126570,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-03T01:30:15.000Z","date":"2020-05-29","kind":"sale","acquired":false,"shares":115600,"price":14.09,"value":1628804.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $13.93 to $14.29 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 1, 2020, the date of the latest transaction reported in this statement, PWIMF held 2,394,058 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 235,651 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3214109,"source":{"system":"sec-edgar","filing":"0000905718-20-000539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000539/ownership.xml","form_type":"4"}},{"id":3130256,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":31787,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":31787,"derivative":{"exercise_date":"2017-03-27","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":31787},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130255,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":31787,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-27","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":31787},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130254,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":168213,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":168213,"derivative":{"exercise_date":"2017-03-24","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":168213},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130253,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":168213,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-24","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":168213},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130252,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":30000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":30000,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130251,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":30000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130250,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":300000,"derivative":{"exercise_date":"2016-10-12","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130249,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-12","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130248,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":800000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":800000,"derivative":{"exercise_date":"2016-10-06","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130247,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":800000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-06","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130246,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":410000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":410000,"derivative":{"exercise_date":"2016-10-05","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130245,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":410000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-05","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130244,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":true,"shares":340000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":340000,"derivative":{"exercise_date":"2016-10-04","expiration_date":"2020-06-04","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130243,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:10:01.000Z","date":"2019-06-03","kind":"other","acquired":false,"shares":340000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2019 to June 4, 2020 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company(\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-04","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000905718-20-000531","document":"kindredbiosc_fm4jun32019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000531/kindredbiosc_fm4jun32019.xml","form_type":"4"}},{"id":3130242,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:07:16.000Z","date":"2020-05-28","kind":"other","acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.13 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,185,000."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.13 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,185,000."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.13 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,185,000."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"During the term of the equity swaps, all dividends earned on the shares of Common Stock underlying the equity swaps were required to be paid to the Reporting Person, and the Reporting Person paid to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905718-20-000529","document":"kindredbiosc_fm4may282020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000529/kindredbiosc_fm4may282020.xml","form_type":"4"}},{"id":3130241,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:07:16.000Z","date":"2020-05-28","kind":"other","acquired":false,"shares":790707,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 790,707 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission) for 110,698 shares, and for a market value of $3.95 per share (net of a $0.15 sale commission) for 680,009 shares. The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $3,183,158."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 790,707 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission) for 110,698 shares, and for a market value of $3.95 per share (net of a $0.15 sale commission) for 680,009 shares. The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $3,183,158."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 790,707 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission) for 110,698 shares, and for a market value of $3.95 per share (net of a $0.15 sale commission) for 680,009 shares. The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $3,183,158."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"During the term of the equity swaps, all dividends earned on the shares of Common Stock underlying the equity swaps were required to be paid to the Reporting Person, and the Reporting Person paid to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-06","underlying":"Common Stock","underlying_shares":790707},"source":{"system":"sec-edgar","filing":"0000905718-20-000529","document":"kindredbiosc_fm4may282020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000529/kindredbiosc_fm4may282020.xml","form_type":"4"}},{"id":3130240,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:07:16.000Z","date":"2020-05-28","kind":"other","acquired":false,"shares":289302,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 289,302 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,299,197."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 289,302 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,299,197."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 289,302 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $4.4908 per share (net of a $0.02 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,299,197."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"During the term of the equity swaps, all dividends earned on the shares of Common Stock underlying the equity swaps were required to be paid to the Reporting Person, and the Reporting Person paid to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-05","underlying":"Common Stock","underlying_shares":289302},"source":{"system":"sec-edgar","filing":"0000905718-20-000529","document":"kindredbiosc_fm4may282020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000529/kindredbiosc_fm4may282020.xml","form_type":"4"}},{"id":3130239,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T22:07:16.000Z","date":"2020-05-28","kind":"other","acquired":false,"shares":340000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 340,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.0799 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,343,000."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 340,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.0799 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,343,000."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 340,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.0799 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to all remaining shares, for a market value of $3.95 per share (net of a $0.15 sale commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $1,343,000."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"During the term of the equity swaps, all dividends earned on the shares of Common Stock underlying the equity swaps were required to be paid to the Reporting Person, and the Reporting Person paid to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). On May 28, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-04","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000905718-20-000529","document":"kindredbiosc_fm4may282020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000529/kindredbiosc_fm4may282020.xml","form_type":"4"}},{"id":3131797,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":28117,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 28,117 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,117 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $128,500."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F8","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 28,117 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,117 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $128,500."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 28,117 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,117 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $128,500."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-27","underlying":"Common Stock","underlying_shares":28117},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131796,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":30669,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-24","underlying":"Common Stock","underlying_shares":30669},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131795,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":30000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $6.5792 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,000 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $137,106."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $6.5792 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,000 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $137,106."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $6.5792 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,000 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $137,106."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-02-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131794,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":9293,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 9,293 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $42,471. The equity swap remains in place upon its original terms with respect to the remaining 790,707 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 9,293 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $42,471. The equity swap remains in place upon its original terms with respect to the remaining 790,707 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 9,293 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $42,471. The equity swap remains in place upon its original terms with respect to the remaining 790,707 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":790707,"derivative":{"exercise_date":"2016-10-06","underlying":"Common Stock","underlying_shares":9293},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131793,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":82941,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":289302,"derivative":{"exercise_date":"2016-10-05","underlying":"Common Stock","underlying_shares":82941},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131792,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-26","kind":"other","acquired":false,"shares":119955,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 150,624 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 119,955 shares, for an average market value of $4.9658 per share (net of the Sale Commission). Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to the remaining 30,669 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $735,835."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":30669,"derivative":{"exercise_date":"2017-03-24","underlying":"Common Stock","underlying_shares":119955},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3131791,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-29T01:58:32.000Z","date":"2020-05-26","kind":"other","acquired":false,"shares":28760,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person had previously entered into an equity swap with the Counterparty for 401,003 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares.  Upon the May 26 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 28,760 shares, for an average market value of $4.9658 per share (net of a $0.02 per share commission (the \"Sale Commission\"))."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the May 27 Cancellation Date, the Reporting Person terminated the equity swap early with respect to 82,941 shares, for an average market value of $4.5702 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such terminations was approximately $521,872. The equity swap remains in place upon its original terms with respect to the remaining 289,302 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\").On May 26, 2020 (the \"May 26 Cancellation Date\") and May 27, 2020 (the \"May 27 Cancellation Date\") the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Of the aggregate of 1,080,009 shares of Common Stock currently underlying the equity swaps following the transactions described herein, PWIMF holds the economic equivalent of 995,204 shares, and PWPI holds the economic equivalent of 84,805 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":372243,"derivative":{"exercise_date":"2016-10-05","underlying":"Common Stock","underlying_shares":28760},"source":{"system":"sec-edgar","filing":"0000905718-20-000518","document":"kindredbiosc_fm4may262020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000518/kindredbiosc_fm4may262020.xml","form_type":"4"}},{"id":3136661,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-22T23:32:00.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":3670,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Sales Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 3,670 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $17,941. The equity swap remains in place upon its original terms with respect to the remaining 28,117 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Sales Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 3,670 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $17,941. The equity swap remains in place upon its original terms with respect to the remaining 28,117 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1237 per share (including the Sales Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 3,670 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $17,941. The equity swap remains in place upon its original terms with respect to the remaining 28,117 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Of the aggregate of 579,744 shares of Common Stock currently underlying the equity swaps, PWIMF held the economic equivalent of 540,229 shares, and PWPI held the economic equivalent of 39,515 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":28117,"derivative":{"exercise_date":"2017-03-27","underlying":"Common Stock","underlying_shares":3670},"source":{"system":"sec-edgar","filing":"0000905718-20-000514","document":"kindredbiosc_fm4may202020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000514/kindredbiosc_fm4may202020.xml","form_type":"4"}},{"id":3136660,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-22T23:32:00.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":17589,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 17,589 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $85,989. The equity swap remains in place upon its original terms with respect to the remaining 150,624 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 17,589 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $85,989. The equity swap remains in place upon its original terms with respect to the remaining 150,624 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $7.1531 per share (including the Purchase Commission), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 17,589 shares, for an average market value of $4.8888 per share (net of the Sale Commission). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $85,989. The equity swap remains in place upon its original terms with respect to the remaining 150,624 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Of the aggregate of 579,744 shares of Common Stock currently underlying the equity swaps, PWIMF held the economic equivalent of 540,229 shares, and PWPI held the economic equivalent of 39,515 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":150624,"derivative":{"exercise_date":"2017-03-24","underlying":"Common Stock","underlying_shares":17589},"source":{"system":"sec-edgar","filing":"0000905718-20-000514","document":"kindredbiosc_fm4may202020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000514/kindredbiosc_fm4may202020.xml","form_type":"4"}},{"id":3136659,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2020-05-22T23:32:00.000Z","date":"2020-05-20","kind":"other","acquired":false,"shares":8997,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 8,997 shares, for an average market value of $4.8888 per share (net of a $0.02 per share commission (the \"Sale Commission\")). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $43,984. The equity swap remains in place upon its original terms with respect to the remaining 401,003 shares of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 8,997 shares, for an average market value of $4.8888 per share (net of a $0.02 per share commission (the \"Sale Commission\")). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $43,984. The equity swap remains in place upon its original terms with respect to the remaining 401,003 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person is obligated to pay to the Counterparty $5.18 per share (including a $0.03 per share commission (the \"Purchase Commission\")), and (ii) the Counterparty is obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares. Upon the Cancellation Date, the Reporting Person terminated the equity swap early with respect to 8,997 shares, for an average market value of $4.8888 per share (net of a $0.02 per share commission (the \"Sale Commission\")). The net payment by the Reporting Person to the Counterparty in connection with such termination was approximately $43,984. The equity swap remains in place upon its original terms with respect to the remaining 401,003 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"During the term of the equity swaps, any dividends earned on the shares of Common Stock underlying the equity swaps are required to be paid to the Reporting Person, and the Reporting Person must pay to the Counterparty \"interest\" on the aggregate swap amount at the Federal Funds rate plus 30 basis points."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person previously entered into certain equity swaps with a securities broker (the \"Counterparty\"), as described below, covering certain shares of Common Stock, par value $0.0001 per share (the \"Common Stock\"), of Kindred Biosciences, Inc. (the \"Company\"). The equity swaps are scheduled to expire on June 4, 2020 (the \"Settlement Date\"). However, on May 20, 2020 (the \"Cancellation Date\"), the Reporting Person agreed with the Counterparty to terminate the equity swaps early with respect to certain shares for the payments described below."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Of the aggregate of 579,744 shares of Common Stock currently underlying the equity swaps, PWIMF held the economic equivalent of 540,229 shares, and PWPI held the economic equivalent of 39,515 shares. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":401003,"derivative":{"exercise_date":"2016-10-05","underlying":"Common Stock","underlying_shares":8977},"source":{"system":"sec-edgar","filing":"0000905718-20-000514","document":"kindredbiosc_fm4may202020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571820000514/kindredbiosc_fm4may202020.xml","form_type":"4"}},{"id":3142705,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-05-19T20:26:32.000Z","date":"2020-05-15","kind":"purchase","acquired":true,"shares":6000,"price":1000,"value":6000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Convertible Preferred Stock, par value $0.001 per share (\"Series B Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $3.10), in each case subject to customary adjustments under the certificate of designations for the Series B Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series B Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock, par value $0.001 per share (\"Series B Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $3.10), in each case subject to customary adjustments under the certificate of designations for the Series B Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series B Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series B Convertible Preferred Stock, par value $0.001 per share (\"Series B Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $3.10), in each case subject to customary adjustments under the certificate of designations for the Series B Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series B Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, together with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As of May 15, 2020, PWIMF held 5,450 shares of Series B Preferred Stock and PWPI held 550 shares of Series B Preferred Stock. The Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6000,"derivative":{"exercise_price":3.1,"exercise_date":"2020-05-15","underlying":"Common Stock","underlying_shares":1935483},"source":{"system":"sec-edgar","filing":"0000905718-20-000470","document":"plxpharma_fm4may152020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000090571820000470/plxpharma_fm4may152020.xml","form_type":"4"}},{"id":3487394,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-17T20:30:21.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":79709,"price":12.96,"value":1033028.64,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $12.75 to $13.10 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 14, 2019, the date of the latest transaction reported in this statement, PWIMF held 3,024,490 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 305,219 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3329709,"source":{"system":"sec-edgar","filing":"0000905718-19-000541","document":"sciplay_fm4jun132019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571819000541/sciplay_fm4jun132019.xml","form_type":"4"}},{"id":3487393,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-17T20:30:21.000Z","date":"2019-06-13","kind":"purchase","acquired":true,"shares":250000,"price":13.52,"value":3380000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $13.10 to $13.61 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"On June 14, 2019, the date of the latest transaction reported in this statement, PWIMF held 3,024,490 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 305,219 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3250000,"source":{"system":"sec-edgar","filing":"0000905718-19-000541","document":"sciplay_fm4jun132019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571819000541/sciplay_fm4jun132019.xml","form_type":"4"}},{"id":3518055,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-20T20:35:43.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":497500,"price":15.93,"value":7925175.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $15.50 to $16.00 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On May 16, 2019, the date of the event which requires the filing of this statement, PWIMF held 2,720,620 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 279,380 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":3000000,"source":{"system":"sec-edgar","filing":"0000905718-19-000474","document":"sciplay_fm4may162019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571819000474/sciplay_fm4may162019.xml","form_type":"4"}},{"id":3531199,"issuer":{"id":92802,"kind":"organization","name":"SciPlay Corp","symbol":"SCPL"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-10T21:29:28.000Z","date":"2019-05-08","kind":"purchase","acquired":true,"shares":250000,"price":15.15,"value":3787500.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $14.98 to $15.40 per share, inclusive. The Reporting Person undertakes to provide SciPlay Corp, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"On May 8, 2019, the date of the event which requires the filing of this statement, PWIMF held 2,269,615 shares of Class A Common Stock $0.001 par value per share (the \"Common Stock\") and PWPI held 232,885 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":2502500,"source":{"system":"sec-edgar","filing":"0000905718-19-000431","document":"sciplay_fm4may82019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571819000431/sciplay_fm4may82019.xml","form_type":"4"}},{"id":3638766,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-02-22T16:44:39.000Z","date":"2019-02-20","kind":"purchase","acquired":true,"shares":15000,"price":1000,"value":15000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Convertible Preferred Stock, par value $0.001 per share (\"Series A Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $2.60), in each case subject to customary adjustments under the certificate of designations for the Series A Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series A Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Convertible Preferred Stock, par value $0.001 per share (\"Series A Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $2.60), in each case subject to customary adjustments under the certificate of designations for the Series A Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series A Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series A Convertible Preferred Stock, par value $0.001 per share (\"Series A Preferred Stock\"), of PLx Pharma Inc. (the \"Company\") is convertible at any time into a number of shares of common stock, par value $0.001 (\"Common Stock\"), of the Company equal to the stated value (initially $1,000) divided by the conversion price (initially $2.60), in each case subject to customary adjustments under the certificate of designations for the Series A Preferred Stock (the \"Certificate of Designations\"). Unless converted pursuant to its terms, the Series A Preferred Stock does not expire. The Certificate of Designations prohibits conversion to the extent that the holder, together with its affiliates, would beneficially own in excess of 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, together with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As of February 20, 2019, PWIMF held 13,565 shares of Series A Preferred Stock and PWPI held 1,435 shares of Series A Preferred Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":15000,"derivative":{"exercise_price":2.6,"exercise_date":"2019-02-20","underlying":"Common Stock","underlying_shares":5769230},"source":{"system":"sec-edgar","filing":"0000905718-19-000246","document":"plxpharm_fm4feb202019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000090571819000246/plxpharm_fm4feb202019.xml","form_type":"4"}},{"id":3689134,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2019-01-23T21:23:42.000Z","date":"2019-01-18","kind":"purchase","acquired":true,"shares":741840,"price":9.5,"value":7047480.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of January 18, 2019, PWIMF held 6,096,140 shares of Common Stock, and PWPI held 647,753 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6743893,"source":{"system":"sec-edgar","filing":"0000905718-19-000067","document":"parkwest_fm4jan182019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571819000067/parkwest_fm4jan182019.xml","form_type":"4"}},{"id":3715932,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2018-12-31T16:41:28.000Z","date":"2018-12-20","kind":"purchase","acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 20, 2018, the PW Funds entered into a Purchase Agreement with the Company (the \"Purchase Agreement\"), pursuant to which the PW Funds agreed to purchase 15,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, for an aggregate purchase price of $15,000,000 (the \"Private Placement\"). The closing of the Private Placement is contingent on the Company obtaining stockholder approval of (i) an amendment to the Company's Amended and Restated Certificate of Incorporation to authorize 1,000,000 shares of \"blank check\" preferred stock and (ii) the issuance of more than 20% of the Common Stock in the Private Placement for purposes of Nasdaq Listing Rule 5635 (the \"Stockholder Approval\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Company issued the Commitment Warrants at no additional cost, in consideration of the PW Funds' commitments pursuant to the Purchase Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 20, 2018, the PW Funds entered into a Purchase Agreement with the Company (the \"Purchase Agreement\"), pursuant to which the PW Funds agreed to purchase 15,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, for an aggregate purchase price of $15,000,000 (the \"Private Placement\"). The closing of the Private Placement is contingent on the Company obtaining stockholder approval of (i) an amendment to the Company's Amended and Restated Certificate of Incorporation to authorize 1,000,000 shares of \"blank check\" preferred stock and (ii) the issuance of more than 20% of the Common Stock in the Private Placement for purposes of Nasdaq Listing Rule 5635 (the \"Stockholder Approval\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrants reported on this Form 4 (the \"Commitment Warrants\") are only exercisable to the extent that the Company does not obtain the Stockholder Approval by April 15, 2019 (the \"Exercisability Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 20, 2018, the PW Funds entered into a Purchase Agreement with the Company (the \"Purchase Agreement\"), pursuant to which the PW Funds agreed to purchase 15,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, for an aggregate purchase price of $15,000,000 (the \"Private Placement\"). The closing of the Private Placement is contingent on the Company obtaining stockholder approval of (i) an amendment to the Company's Amended and Restated Certificate of Incorporation to authorize 1,000,000 shares of \"blank check\" preferred stock and (ii) the issuance of more than 20% of the Common Stock in the Private Placement for purposes of Nasdaq Listing Rule 5635 (the \"Stockholder Approval\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Commitment Warrants expire on the tenth anniversary of the Exercisability Date and will be surrendered to the Company for cancellation if the Stockholder Approval is obtained on or prior to the Exercisability Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, together with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As of December 20, 2018, PWIMF held Commitment Warrants to purchase up to 452,135 shares of Common Stock and PWPI held Commitment Warrants to purchase up to 47,865 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":500000,"derivative":{"exercise_price":3.5,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000905718-18-001018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000090571818001018/ownership.xml","form_type":"4"}},{"id":3715931,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2018-12-31T16:41:28.000Z","date":"2018-12-27","kind":"purchase","acquired":true,"shares":397495,"price":1,"value":397495.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\" and, together with PWIMF, the \"PW Funds\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As of December 27, 2018, PWIMF held 1,332,191 shares of common stock, par value $0.001 per share (the \"Common Stock\"), of PLx Pharma Inc. (the \"Company\"), and PWPI held 141,027 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":1473218,"source":{"system":"sec-edgar","filing":"0000905718-18-001018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000090571818001018/ownership.xml","form_type":"4"}},{"id":3884724,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-06-22T20:48:13.000Z","date":"2018-06-20","kind":"purchase","acquired":true,"shares":845262,"price":9.5,"value":8029989.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of June 20, 2018, PWIMF held 5,397,002 shares of Common Stock, and PWPI held 605,051 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6002053,"source":{"system":"sec-edgar","filing":"0000905718-18-000596","document":"kindredbiosc_fm4jun202018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000596/kindredbiosc_fm4jun202018.xml","form_type":"4"}},{"id":3936712,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":31787,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":31787,"derivative":{"exercise_date":"2017-03-27","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":31787},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936711,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":31787,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Commencing March 27, 2017, the Reporting Person entered into an equity swap with the Counterparty for 31,787 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $226,441, representing $7.1237 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-27","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":31787},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936710,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":168213,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":168213,"derivative":{"exercise_date":"2017-03-24","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":168213},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936709,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":168213,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Commencing March 24, 2017, the Reporting Person entered into an equity swap with the Counterparty for 168,213 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty approximately $1,203,244, representing $7.1531 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-03-24","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":168213},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936708,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":30000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":30000,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936707,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":30000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Commencing February 1, 2017, the Reporting Person entered into an equity swap with the Counterparty for 30,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $197,376, representing $6.5792 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2017-02-01","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936706,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":300000,"derivative":{"exercise_date":"2016-10-12","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936705,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Commencing October 12, 2016, the Reporting Person entered into an equity swap with the Counterparty for 300,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,539,000, representing $5.13 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-12","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936704,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":800000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":800000,"derivative":{"exercise_date":"2016-10-06","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936703,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":800000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Commencing October 6, 2016, the Reporting Person entered into an equity swap with the Counterparty for 800,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $4,144,000, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-06","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936702,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":410000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":410000,"derivative":{"exercise_date":"2016-10-05","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936701,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":410000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Commencing October 5, 2016, the Reporting Person entered into an equity swap with the Counterparty for 410,000 shares of Common Stock, under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $2,123,800, representing $5.18 per share (including the Commission), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-05","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936700,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":true,"shares":340000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":340000,"derivative":{"exercise_date":"2016-10-04","expiration_date":"2019-06-04","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":3936699,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Equity Swap","published_at":"2018-05-12T01:30:18.000Z","date":"2018-02-15","kind":"other","acquired":false,"shares":340000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 15, 2018, the Reporting Person amended its equity swap agreement with a securities broker (the \"Counterparty\") to extend the settlement date for its equity swaps under that agreement from June 4, 2018 to June 4, 2019 (the \"Settlement Date\"), for no additional consideration. The extension of the settlement date resulted in a deemed cancellation of the Reporting Person's existing equity swaps thereunder, and a deemed reentry into new equity swaps with a later settlement date. The deemed cancellation is exempt from liability under Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-6(d) promulgated thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Commencing October 4, 2016, the Reporting Person entered into an equity swap with a securities broker (the \"Counterparty\") for 340,000 shares of Common Stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), under which, on the Settlement Date, (i) the Reporting Person will be obligated to pay to the Counterparty $1,727,166, representing $5.0799 per share (including a $0.03 per share commission (the \"Commission\")), and (ii) the Counterparty will be obligated to pay to the Reporting Person the aggregate market value as of the Settlement Date for such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"During the term of the equity swap agreement, any dividends earned on the shares of Common Stock underlying the equity swaps will be paid to the Reporting Person, and the Reporting Person will pay to the Counterparty \"interest\" on the aggregate swap amount of approximately $11,161,027, at the Federal Funds rate plus 30 basis points. Of the aggregate of 2,080,000 shares of Common Stock currently underlying the equity swaps, PWIMF holds the economic equivalent of 1,839,846 shares, and PWPI holds the economic equivalent of 240,154 shares. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":0,"derivative":{"exercise_date":"2016-10-04","expiration_date":"2018-06-04","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000905718-18-000474","document":"kindredbiosc_fm4feb122018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571818000474/kindredbiosc_fm4feb122018.xml","form_type":"4"}},{"id":4247075,"issuer":{"id":159591,"kind":"organization","name":"Nexeo Solutions, Inc.","symbol":"NXEO"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-08-01T23:07:04.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":2000000,"price":8.15,"value":16300000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of Reporting Person. As of July 31, 2017, PWIMF held 5,614,684 shares of Common Stock (including 3,685,393 Founder Shares (as defined in the Form 10-Q for the quarterly period ended March 31, 2017, filed with the Securities and Exchange Commission on May 10, 2017)), and PWPI held 727,815 shares of Common Stock (including 482,972 Founder Shares). Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":6342499,"source":{"system":"sec-edgar","filing":"0000905718-17-000743","document":"nexeo_fm4jul312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571817000743/nexeo_fm4jul312017.xml","form_type":"4"}},{"id":4249222,"issuer":{"id":159591,"kind":"organization","name":"Nexeo Solutions, Inc.","symbol":"NXEO"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-07-29T01:29:57.000Z","date":"2017-07-26","kind":"sale","acquired":false,"shares":7796,"price":8.489,"value":66180.244,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were sold in multiple transactions at prices ranging from $8.475 to $8.500, inclusive. Park West Asset Management LLC (the \"Reporting Person\") undertakes to provide to Nexeo Solutions, Inc., any security holder of Nexeo Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of Reporting Person. As of July 26, 2017, PWIMF held 7,377,397 shares of Common Stock (including 3,685,393 Founder Shares (as defined in the Form 10-Q for the quarterly period ended March 31, 2017, filed with the Securities and Exchange Commission on May 10, 2017)), and PWPI held 965,102 shares of Common Stock (including 482,972 Founder Shares). Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":8342499,"source":{"system":"sec-edgar","filing":"0000905718-17-000735","document":"nexeo_fm4jul262017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571817000735/nexeo_fm4jul262017.xml","form_type":"4"}},{"id":4250323,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-27T21:32:39.000Z","date":"2017-07-25","kind":"sale","acquired":false,"shares":2250000,"price":3.877,"value":8723250.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at prices ranging from $3.850 to $3.925, inclusive. The Reporting Person undertakes to provide to Internap Corporation, any security holder of Internap Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 25, 2017, PWIMF held 7,281,189 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 922,540 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":8203729,"source":{"system":"sec-edgar","filing":"0000905718-17-000733","document":"internapcorp_fm4july252017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000733/internapcorp_fm4july252017.xml","form_type":"4"}},{"id":4251708,"issuer":{"id":159591,"kind":"organization","name":"Nexeo Solutions, Inc.","symbol":"NXEO"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-07-26T01:31:38.000Z","date":"2017-07-21","kind":"sale","acquired":false,"shares":10000,"price":8.43,"value":84300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of Reporting Person. As of July 21, 2017, PWIMF held 7,384,317 shares of Common Stock (including 3,685,393 Founder Shares (as defined in the Form 10-Q for the quarterly period ended March 31, 2017, filed with the Securities and Exchange Commission on May 10, 2017)), and PWPI held 965,978 shares of Common Stock (including 482,972 Founder Shares). Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":8350295,"source":{"system":"sec-edgar","filing":"0000905718-17-000725","document":"nexeo_fm4jun212017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571817000725/nexeo_fm4jun212017.xml","form_type":"4"}},{"id":4252023,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-25T21:30:16.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":675000,"price":3.9,"value":2632500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\").  Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 24, 2017, PWIMF held 9,278,167 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,175,562 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":10453729,"source":{"system":"sec-edgar","filing":"0000905718-17-000724","document":"internapcorp_fm4july212017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000724/internapcorp_fm4july212017.xml","form_type":"4"}},{"id":4252022,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-25T21:30:16.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":12700,"price":3.902,"value":49555.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at prices ranging from $3.900 to $3.915, inclusive. The Reporting Person undertakes to provide to Internap Corporation, any security holder of Internap Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\").  Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 24, 2017, PWIMF held 9,278,167 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,175,562 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":11128729,"source":{"system":"sec-edgar","filing":"0000905718-17-000724","document":"internapcorp_fm4july212017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000724/internapcorp_fm4july212017.xml","form_type":"4"}},{"id":4252021,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-25T21:30:16.000Z","date":"2017-07-21","kind":"sale","acquired":false,"shares":270000,"price":4.043,"value":1091610.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\").  Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 24, 2017, PWIMF held 9,278,167 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,175,562 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":11141429,"source":{"system":"sec-edgar","filing":"0000905718-17-000724","document":"internapcorp_fm4july212017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000724/internapcorp_fm4july212017.xml","form_type":"4"}},{"id":4252020,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-25T21:30:16.000Z","date":"2017-07-21","kind":"sale","acquired":false,"shares":150000,"price":4.078,"value":611700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\").  Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 24, 2017, PWIMF held 9,278,167 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,175,562 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":11411429,"source":{"system":"sec-edgar","filing":"0000905718-17-000724","document":"internapcorp_fm4july212017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000724/internapcorp_fm4july212017.xml","form_type":"4"}},{"id":4252724,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-24T21:31:08.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":100000,"price":4.19,"value":419000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 20, 2017, PWIMF held 10,262,252 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,299,177 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":11561429,"source":{"system":"sec-edgar","filing":"0000905718-17-000721","document":"internapcorp_fm4july202017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000721/internapcorp_fm4july202017.xml","form_type":"4"}},{"id":4252723,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2017-07-24T21:31:08.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":25000,"price":4.17,"value":104250.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of the Reporting Person. As of July 20, 2017, PWIMF held 10,262,252 shares of Common Stock $.0001 par value per share (the \"Common Stock\") and PWPI held 1,299,177 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":11661429,"source":{"system":"sec-edgar","filing":"0000905718-17-000721","document":"internapcorp_fm4july202017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000721/internapcorp_fm4july202017.xml","form_type":"4"}},{"id":4254031,"issuer":{"id":149167,"kind":"organization","name":"Internap Corp","symbol":"INAP"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Options (obligation to sell)","published_at":"2017-07-20T21:30:33.000Z","date":"2017-07-18","kind":"sale","acquired":false,"shares":20000,"price":48.96,"value":979200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of Reporting Person. As of July 18, 2017, PWIMF was the obligor under 17,751 call options, and PWPI was the obligor under 2,249 call options. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":20000,"derivative":{"exercise_price":4,"exercise_date":"2017-07-18","expiration_date":"2017-10-20","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000905718-17-000716","document":"internapcorp_fm4july182017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1056386/000090571817000716/internapcorp_fm4july182017.xml","form_type":"4"}},{"id":4256983,"issuer":{"id":135544,"kind":"organization","name":"Kindred Biosciences, Inc.","symbol":"KIN"},"owners":[{"id":114407,"kind":"organization","name":"Park West Asset Management LLC","position":1,"cik":"0001386928","reported_name":"Park West Asset Management LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-07-14T21:27:50.000Z","date":"2017-07-12","kind":"purchase","acquired":true,"shares":600000,"price":7.5,"value":4500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Park West Asset Management LLC (the \"Reporting Person\") is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (\"PWIMF\"), and Park West Partners International, Limited, a Cayman Islands exempted company (\"PWPI\"). Peter S. Park (\"Mr. Park\") is the sole member and manager of Reporting Person. As of July 12, 2017, PWIMF held 4,576,666 shares of Common Stock, and PWPI held 580,125 shares of Common Stock. Pursuant to Reg. Section 240.16a-1(a)(2), the Reporting Person's and Mr. Park's beneficial ownership is limited to their pecuniary interest, if any, in such securities."}],"balance_after":5156791,"source":{"system":"sec-edgar","filing":"0000905718-17-000704","document":"kindredbiosc_fm4jul122017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386928/000090571817000704/kindredbiosc_fm4jul122017.xml","form_type":"4"}}],"next_cursor":"2017-07-14T21:27:50.000000Z,4256983"}